161P A phase Ib study to evaluate IK-007 in combination with pembrolizumab (pembro) in patients with advanced microsatellite stable (MSS) colorectal cancer (CRC). (December 2022) - Tolcher, A.W.; Spigel, D.R.; Leal, A.D.; Bekaii-Saab, T.; Lingaraj, T.; Talcove-Berko, E.; Ortiz-Otero, N.; Bartolini, W.; Kacena, K.; Chisamore, M.; Santillana, S.L.